- Market Realist•5 hours ago
GlaxoSmithKline (GSK) reported a 10.9% increase in its top line in its 2Q16 earnings on July 27, 2016. It met Wall Street analysts’ estimates for revenues and EPS.
- Investor's Business Daily•yesterday
When Peter Gassner started Veeva in 2007, he had one primary goal -- replace biopharma companies' legacy systems with cloud-based software.
After hours: 45.06-0.01 (-0.02%) as of 4:51 PM EDT
|Bid||45.00 x 200|
|Ask||45.34 x 300|
|52wk Range||37.24 - 45.49|
|Day's Range||44.85 - 45.38|
|Avg Vol (3m)||3,515,277|
As of 4:02 PM EDT. Market closed.